64 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
government regulations may be enacted that could impair our business. We also cannot predict the likelihood, nature or extent of government regulation … . In addition, we intend to promptly disclose (1) the nature of any amendment to our Code of Business Conduct and Ethics that applies to our principal
8-K
EX-1.1
ha8faxkqp0eshct9xk7
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
7890uh8z7fd4ma8e
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
EX-10.1
uj206
11 May 23
Departure of Directors or Certain Officers
4:00pm
8-K
f3wm0jyf6p5l8zk
30 Nov 22
Other Events
10:07am
PRE 14A
7etaleo 3c9
12 Mar 21
Preliminary proxy
8:30am